Lynn Rothman, the Executive Vice President and Chief Business Officer of Penumbra, Inc., Notifies Her Departure
April 08, 2022 at 04:22 pm EDT
Share
On April 4, 2022, Lynn Rothman, the Executive Vice President and Chief Business Officer of Penumbra, Inc., notified the company of her departure, effective May 2, 2022, in order to start a non-profit organization focused on education.
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.